No insider has filed a notice of proposed sale (Form 144) for CASI Pharmaceuticals Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
ST
Simplex Trading, LLC
|
— | — | SOLD OUT | — | 0.0% | |
|
Shares held by quarter
|
||||||
|
WP
West Paces Advisors Inc.
|
100 | 0.00% | NEW | Q2 '26 | 0.0% | |
|
Shares held by quarter
Peak holding100 (Q3'24)
Change over 8 quarters0
Share of the company0.000%
|
||||||
| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$82.9K | 32.4K | 0.16% | 0.00% | September 30, 2023 |
|
AD
Allianz Variable Insurance Products Trust
|
$513 | 142 | 0.00% | 0.00% | March 31, 2024 |
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
WH
WEI-WU HE, Ph.D.
5%+ holder
13D · 58.8%
|
24.0M | 116.68% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
JH
James Huang
5%+ holder
13D · 22.5%
|
4.7M | 22.63% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of CASI Pharmaceuticals Inc.
Sign up freeLoading...